Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

3,6'-Dithiopomalidomide shows promise for treating AD

March 18, 2022

Researchers describe new ghrelin receptor GHSR1a ligand to modulate brain dopamine

March 18, 2022

Elamipretide potentiates dystrophin expression induced by PMO in a murine model of DMD

March 18, 2022

In vivo pharmacokinetic data confirm BETR-001 bioavailability in target brain tissue

March 17, 2022

PepGen presents promising preclinical data for PGN-EDO51

March 17, 2022

Blood stem cells treat brain disease after transplant

March 17, 2022

RGX-202 improves muscle function and dystrophic muscle pathology in mice

March 17, 2022

New GSK-3 inhibitors patented by Ramot at Tel Aviv University, Bar-Ilan University

March 17, 2022

New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics

March 17, 2022

Satellos advances compounds to modulate muscle stem cell polarity for Duchenne muscular dystrophy

March 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...